Quest Diagnostics Return on Tangible Equity 2010-2024 | DGX

Current and historical return on tangible equity values for Quest Diagnostics (DGX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Quest Diagnostics Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-03-31 $0.84B $-2.55B -32.73%
2023-12-31 $0.85B $-2.56B -34.11%
2023-09-30 $0.76B $-2.49B -31.00%
2023-06-30 $0.79B $-2.69B -33.84%
2023-03-31 $0.79B $-2.23B -36.98%
2022-12-31 $0.94B $-2.38B -45.63%
2022-09-30 $1.23B $-2.03B -64.11%
2022-06-30 $1.48B $-1.89B -79.79%
2022-03-31 $1.87B $-1.95B -96.26%
2021-12-31 $1.99B $-1.78B -112.73%
2021-09-30 $2.18B $-1.78B -133.91%
2021-06-30 $2.24B $-2.28B -141.05%
2021-03-31 $1.80B $-1.22B -117.19%
2020-12-31 $1.43B $-1.23B -81.02%
2020-09-30 $1.11B $-1.63B -56.26%
2020-06-30 $0.75B $-2.05B -36.10%
2020-03-31 $0.79B $-2.13B -37.10%
2019-12-31 $0.86B $-2.05B -38.62%
2019-09-30 $0.73B $-2.10B -31.36%
2019-06-30 $0.73B $-2.27B -30.79%
2019-03-31 $0.72B $-2.46B -30.33%
2018-12-31 $0.74B $-2.50B -30.76%
2018-09-30 $0.86B $-2.25B -36.09%
2018-06-30 $0.81B $-2.32B -33.51%
2018-03-31 $0.79B $-2.50B -32.51%
2017-12-31 $0.77B $-2.50B -32.74%
2017-09-30 $0.67B $-2.37B -29.06%
2017-06-30 $0.70B $-2.30B -30.70%
2017-03-31 $0.70B $-2.27B -30.38%
2016-12-31 $0.64B $-2.29B -27.55%
2016-09-30 $0.68B $-2.28B -29.32%
2016-06-30 $0.83B $-2.42B -35.83%
2016-03-31 $0.75B $-2.34B -31.64%
2015-12-31 $0.71B $-2.18B -28.60%
2015-09-30 $0.71B $-2.28B -27.16%
2015-06-30 $0.50B $-2.67B -17.94%
2015-03-31 $0.51B $-2.76B -17.90%
2014-12-31 $0.56B $-2.77B -19.03%
2014-09-30 $0.51B $-2.91B -17.73%
2014-06-30 $0.79B $-3.02B -27.95%
2014-03-31 $0.82B $-2.98B -30.07%
2013-12-31 $0.85B $-2.57B -33.32%
2013-09-30 $0.76B $-2.66B -30.97%
2013-06-30 $0.52B $-2.66B -21.17%
2013-03-31 $0.53B $-2.30B -21.35%
2012-12-31 $0.56B $-2.22B -20.86%
2012-09-30 $0.69B $-2.64B -23.88%
2012-06-30 $0.70B $-2.82B -22.88%
2012-03-31 $0.68B $-2.98B -21.29%
2011-12-31 $0.47B $-3.12B -15.02%
2011-09-30 $0.45B $-3.31B -15.86%
2011-06-30 $0.47B $-3.45B -18.93%
2011-03-31 $0.51B $-2.68B -23.87%
2010-12-31 $0.72B $-1.84B -37.18%
2010-09-30 $0.74B $-2.03B -37.76%
2010-06-30 $0.73B $-1.92B -37.66%
2010-03-31 $0.72B $-1.97B -36.34%
2009-12-31 $0.73B $-1.90B -35.04%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.508B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.162B 10.99
DaVita (DVA) United States $12.078B 15.00
Encompass Health (EHC) United States $8.774B 22.46
Chemed (CHE) United States $8.268B 25.63
Elanco Animal Health (ELAN) United States $6.548B 16.99
Option Care Health (OPCH) United States $5.428B 20.55
RadNet (RDNT) United States $4.814B 100.25
Amedisys (AMED) United States $3.194B 22.62
Astrana Health (ASTH) United States $2.853B 38.60
Addus HomeCare (ADUS) United States $2.223B 28.77
LifeStance Health (LFST) United States $2.164B 0.00
U.S Physical Therapy (USPH) United States $1.487B 39.79
Pennant (PNTG) United States $0.823B 43.48
Aveanna Healthcare Holdings (AVAH) United States $0.708B 0.00
Atai Life Sciences (ATAI) Germany $0.275B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.020B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00